Compare Amphastar Pharmaceuticals Inc (AMPH) vs GraniteShares 2x Long COIN Daily ETF (CONL) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

CONL, the GraniteShares 2x Long COIN Daily ETF, trades at $4.95 with a slight 0.61% daily gain. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. The ETF has experienced significant volatility, losing 67% year-to-date according to 24/7 Wall Street (June 6, 2026), reflecting the amplified risks of daily-reset leverage on Coinbase stock performance.

The outlook remains highly speculative with potential for explosive gains if Bitcoin rallies toward $100,000, but investors face substantial volatility decay risks. Recent cryptocurrency momentum provides short-term catalysts, though the leveraged structure makes CONL suitable only for sophisticated traders comfortable with rapid capital erosion during market whipsaws.